Research programme: G-protein-coupled receptor modulator antibodies - iHuman Institute/Bird Rock Bio
Latest Information Update: 12 Apr 2016
At a glance
- Originator iHuman Institute; RuiYi
- Developer Bird Rock Bio; iHuman Institute
- Class Monoclonal antibodies
- Mechanism of Action G protein-coupled receptor agonists; G protein-coupled receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 11 Jun 2014 Early research in Undefined indication in China (Parenteral)